increase in open rates
of requests generated by Growth Potential segment
average video completion rate
An American multi-brand pharmaceutical manufacturer needed to re-position as the brand of choice for Myeloid Leukemia therapy, increase NRx and maintain and protect existing Rx. Key barriers included decreased field access, an evolving and highly competitive market, entrenched Rx behaviors with older therapies and payer approval. The company’s objectives included optimizing brand awareness, targeting HCP engagement, driving NRx, maintaining and supporting favorable TRx levels as well as augmenting field force activity.
Dentsu health needed to devise a strategy and communication plan to address different audiences by professional designation and execute based on engagement activity and customer behavior.
Additional solutions included:
Key Opinion Leader (KOL) campaign highlighting proper diagnosis and monitoring of Chronic Myeloid Leukemia
KOL videos and responsive microsite, direct messaging and representative triggered email focused on diagnosis and monitoring
Treatment lines (first line/newly diagnosed and strong second line switch, appropriate patient types and co-pay programs)
Direct mail, representative triggered email and website
Website UX/SEO audit, cross-agency media planning and field communications
Channel performance audit.
The campaign resulted in a spike in representative triggered email activity in support of the new campaign. Email open rates all exceeded 13% and click-through rates ranged 2-5% with over 48% of co-pay requests generated from the highly coveted “Growth Potential” segment. Additionally, USB chip drove substantial percentage of traffic and a 22% average point of decision to drop or watch through video completion.
More case studies
Harvard Pilgrim Healthcare
Dentsu health helped design and implement a go-to-market strategy with a best-in-class campaign that capitalizes on historical learnings, is grounded in data and analytics to inform key decisions and continues the test/learn/apply feedback loop to realize wins in real-time and ensures efficiency.
Multiple Myeloma Customer Centric Multi-Channel Campaign
American Multi-Brand Pharmaceutical Company Increases Oncological Growth Potential by Combining Personal and Digital Promotional Strategies
Cancer Treatments Pharmaceutical Manufacturer
A pharmaceutical corporation specialized in the manufacturing of cancer and immunology drugs needed to design a program to support the launch of its key multiple myeloma (MM) treatment product. 20-28% of physicians had reported some access hurdles when trying to prescribe products from this brand.
U.S. Pharmaceutical Manufacturer
From a diagnostic and descriptive analysis approach, the solution evolved into a robust advanced analytics omnichannel measurement framework that was proactive and prescriptive in nature.
A Top Ten Global Pharmaceutical Company
This dentsu health client recognized the need for a new go-to-market process as well as organizational change management to leverage its technology investments.
Ascensia Diabetes Care
Diabetes management is experiencing a deep industry transformation through technology, innovation and digitalization of the patient journey through services like telehealth and digital pharmacies.